Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 1.050

+7.1%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: gbull who wrote (9825)	7/22/1998 12:47:00 PM
From: dowman	Read Replies (1) of 14328

I believe there have been less than 100 confirmed cases of HIV2 in this country. There is no question that it is a very small problem relative to the question of increased testing. The FDA may change their stance in the future. But when Abbott, for instance, a holder of a valid license enters this market, who will be the winner? I don't own Abbott by the way. They are selling a rapid test overseas, and having bought Murex, they have an interest in this market and will be filing with the FDA at some point. And just call these companies and ask about an HIV2 license. This is not a secret

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next